Cytek Biosciences Inc

CTKB

Company Profile

  • Business description

    Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

  • Contact

    47215 Lakeview Boulevard
    FremontCA94538
    USA

    T: +1 877 922-9835

    https://www.cytekbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    702

Stocks News & Analysis

stocks

Anthropic and OpenAI face commodification threats. Here’s what to watch for

Frontier AI labs face a three-pronged set of challenges.
stocks

Berkshire Hathaway: Abel pushes into new territory with Bending Spoons investment

We think it is a sign that the firm is finally moving out of its comfort zone to find places to put capital to work.
stocks

Overlooked cheap ASX share

The market may be overlooking this share’s long-term value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,975.7035.300.39%
CAC 407,844.89111.81-1.41%
DAX 4025,339.89282.72-1.10%
Dow JONES (US)52,002.41175.28-0.34%
FTSE 10010,785.3696.54-0.89%
HKSE24,186.83124.110.52%
NASDAQ26,140.03572.99-2.14%
Nikkei 22564,916.70407.59-0.62%
NZX 50 Index13,652.07101.66-0.74%
S&P 5007,659.4484.62-1.09%
S&P/ASX 2008,845.7039.000.44%
SSE Composite Index3,716.288.810.24%

Market Movers